Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs

European Journal of Pharmaceutical Sciences

Volumn 27, Issue 1, 2006, Pages 37-43

  Lespine, Anne ^a   Chanoit, Guillaume ^b   Bousquet Melou, Alain ^c   Lallemand, Elodie ^c   Bassissi, Firas Mohamad ^a   Alvinerie, Michel ^a   Toutain, Pierre Louis ^c  

^a CEMAGREF   (France)

^b VETAGRO SUP   (France)

^c CNRS   (France)

Author keywords

Bioavailability; Intestinal absorption; Lipids; Lymph duct cannulated dogs; Lymphatic transport; Macrocyclic lactones; Moxidectin

Indexed keywords

CORN OIL; MOXIDECTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CANNULATION; CONSCIOUSNESS; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG LYMPH LEVEL; DRUG TRANSPORT; INTESTINE ABSORPTION; LYMPH VESSEL; LYMPHATIC SYSTEM; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PLASMA; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 28444470864     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2005.08.003     Document Type: Article

References (21)

1. J. Afzal, A.B. Burke, P.L. Batten, R.L. DeLay, and P. Miller Moxidectin: metabolic fate and blood pharmacokinetics of 14C-labelled moxidectin in horses J. Agric. Food Chem. 45 1997 3627 3633
2. M. Alvinerie, J.F. Sutra, M. Badri, and P. Galtier Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection J. Chromatogr. B: Biomed. Appl. 674 1995 119 124
3. M.F. Bassissi, M. Alvinerie, and A. Lespine Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 138 2004 437 444
4. M.F. Bassissi, A. Lespine, and M. Alvinerie Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration Parasitol. Res. 94 3 2004 188 192
5. A. Bousquet-Melou, S. Mercadier, M. Alvinerie, and P.L. Toutain Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectin Int. J. Parasitol. 34 2004 1299 1307
6. M.M. Cotreau, S. Warren, J.L. Ryan, L. Fleckenstein, S.R. Vanapalli, K.R. Brown, D. Rock, C.Y. Chen, and U.S. Schwertschlag The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans J. Clin. Pharmacol. 43 2003 1108 1115
7. J. Craven, H. Bjorn, D.R. Hennessy, and C. Friis The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs J. Vet. Pharmacol. Ther. 25 2002 227 232
8. A. Dourmishev, D. Serafimova, and L. Dourmishev Efficacy and tolerance of oral ivermectin in scabies J. Eur. Acad. Dermatol. Venereol. 11 1998 247 251
9. G.A. Edwards, C.J. Porter, S.M. Caliph, S.M. Khoo, and W.N. Charman Animal models for the study of intestinal lymphatic drug transport Adv. Drug Deliv. Rev. 50 2001 45 60
10. P. Fossati, and L. Prencipe Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clin. Chem. 28 1982 2077 2080
11. C.A. Guzzo, C.I. Furtek, A.G. Porras, C. Chen, R. Tipping, C.M. Clineschmidt, D.G. Sciberras, J.Y. Hsieh, and K.C. Lasseter Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects J. Clin. Pharmacol. 42 2002 1122 1133
12. D.R. Hennessy, and M.R. Alvinerie Pharmacocinetics of the macrocyclic lactones: conventional wisdom and new paradigms J. Vercruysse R.S. Rew Macrocyclic Lactones in Antiparasitic Therapy 2002 CAB International 97 123
13. R. Holm, C.J. Porter, G.A. Edwards, A. Mullertz, H.G. Kristensen, and W.N. Charman Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides Eur. J. Pharm. Sci. 20 2003 91 97
14. K.G. Kagan, and E.M. Breznock Variations in the canine thoracic duct system and the effects of surgical occlusion demonstrated by rapid aqueous lymphography, using an intestinal lymphatic trunk Am. J. Vet. Res. 40 1979 948 958
15. D. Kerboeuf, J. Hubert, B. Cardinaud, and F. Blond-Riou The persistence of the efficacy of injectable or oral moxidectin against Teladorsagia, Haemonchus and Trichostrongylus species in experimentally infected sheep Vet. Rec. 137 1995 399 401
16. S.M. Khoo, G.A. Edwards, C.J. Porter, and W.N. Charman A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine J. Pharm. Sci. 90 2001 1599 1607
17. Q.A. McKellar, and H.A. Benchaoui Avermectins and milbemycins J. Vet. Pharmacol. Ther. 19 1996 331 351
18. D.H. Molyneux, M. Bradley, A. Hoerauf, D. Kyelem, and M.J. Taylor Mass drug treatment for lymphatic filariasis and onchocerciasis Trends Parasitol. 19 2003 516 522
19. C.M. O'Driscoll Lipid-based formulations for intestinal lymphatic delivery Eur. J. Pharm. Sci. 15 2002 405 415
20. D. Perrier, and M. Mayersohn Noncompartmental determination of the steady-state volume of distribution for any mode of administration J. Pharm. Sci. 71 1982 372 373
21. C.J. Porter, and W.N. Charman Intestinal lymphatic drug transport: an update Adv. Drug Deliv. Rev. 50 2001 61 80